Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
LCAT converts free cholesterol to cholesteryl esters in the process of reverse cholesterol transport. Familial LCAT deficiency (FLD) is a genetic disease that was first described by Kaare R. Norum and Egil Gjone in 1967. This report is a summary from a 2017 symposium where Dr. Norum recounted the hi...
Main Authors: | Kaare R. Norum, Alan T. Remaley, Helena E. Miettinen, Erik H. Strøm, Bruno E.P. Balbo, Carlos A.T.L. Sampaio, Ingrid Wiig, Jan Albert Kuivenhoven, Laura Calabresi, John J. Tesmer, Mingyue Zhou, Dominic S. Ng, Bjørn Skeie, Sotirios K. Karathanasis, Kelly A. Manthei, Kjetil Retterstøl |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520434832 |
Similar Items
-
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
by: Sandra Kunnen, et al.
Published: (2012-09-01) -
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol
by: Kelly A Manthei, et al.
Published: (2018-11-01) -
Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides
by: Marco G. Casteleijn, et al.
Published: (2018-04-01) -
Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity
by: Irina N. Gorshkova, et al.
Published: (2018-02-01) -
Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase
by: Stein Roosbeek, et al.
Published: (2001-01-01)